These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

244 related articles for article (PubMed ID: 23216690)

  • 21. Temporal relationship of first-episode non-affective psychosis with cannabis use: a clinical verification of an epidemiological hypothesis.
    Barrigón ML; Gurpegui M; Ruiz-Veguilla M; Diaz FJ; Anguita M; Sarramea F; Cervilla J
    J Psychiatr Res; 2010 May; 44(7):413-20. PubMed ID: 19900684
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Predicting life-time and regular cannabis use during adolescence; the roles of temperament and peer substance use: the TRAILS study.
    Creemers HE; Dijkstra JK; Vollebergh WA; Ormel J; Verhulst FC; Huizink AC
    Addiction; 2010 Apr; 105(4):699-708. PubMed ID: 20148797
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Predictors of cannabis use in men with and without psychosis.
    Green B; Kavanagh DJ; Young RM
    Addict Behav; 2007 Dec; 32(12):2879-87. PubMed ID: 17544588
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Contributions of parental and social influences to cannabis use in a non-clinical sample of adolescents].
    Chabrol H; Mabila JD; Chauchard E; Mantoulan R; Rousseau A
    Encephale; 2008 Jan; 34(1):8-16. PubMed ID: 18514145
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cannabis--psychosis pathway independent of other types of psychopathology.
    Ferdinand RF; van der Ende J; Bongers I; Selten JP; Huizink A; Verhulst FC
    Schizophr Res; 2005 Nov; 79(2-3):289-95. PubMed ID: 16125368
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Symptomatology and neuropsychological functioning in cannabis using subjects at ultra-high risk for developing psychosis and healthy controls.
    Korver N; Nieman DH; Becker HE; van de Fliert JR; Dingemans PH; de Haan L; Spiering M; Schmitz N; Linszen DH
    Aust N Z J Psychiatry; 2010 Mar; 44(3):230-6. PubMed ID: 20180725
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Psychiatric complications of cannabis use].
    Coscas S; Benyamina A; Reynaud M; Karila L
    Rev Prat; 2013 Dec; 63(10):1426-8. PubMed ID: 24579344
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cannabis and psychosis: what is the link?
    Ben Amar M; Potvin S
    J Psychoactive Drugs; 2007 Jun; 39(2):131-42. PubMed ID: 17703707
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Acute cannabis use causes increased psychotomimetic experiences in individuals prone to psychosis.
    Mason O; Morgan CJ; Dhiman SK; Patel A; Parti N; Patel A; Curran HV
    Psychol Med; 2009 Jun; 39(6):951-6. PubMed ID: 19017430
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Psychotic symptom and cannabis relapse in recent-onset psychosis. Prospective study.
    Hides L; Dawe S; Kavanagh DJ; Young RM
    Br J Psychiatry; 2006 Aug; 189():137-43. PubMed ID: 16880483
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Cannabis consumption and development of psychosis: state of the art].
    Roncero C; Collazos F; Valero S; Casas M
    Actas Esp Psiquiatr; 2007; 35(3):182-9. PubMed ID: 17508295
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Age-varying effects of cannabis use frequency and disorder on symptoms of psychosis, depression and anxiety in adolescents and adults.
    Leadbeater BJ; Ames ME; Linden-Carmichael AN
    Addiction; 2019 Feb; 114(2):278-293. PubMed ID: 30276906
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Understanding cannabis use in first-episode psychosis: an application of the Theory of Planned Behaviour.
    Hames A; Evangeli M; Harrop C; di Forti M
    Early Interv Psychiatry; 2012 Feb; 6(1):38-44. PubMed ID: 22168625
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Neurocognitive moderation of associations between cannabis use and psychoneuroticism.
    Huijbregts SC; Griffith-Lendering MF; Vollebergh WA; Swaab H
    J Clin Exp Neuropsychol; 2014; 36(8):794-805. PubMed ID: 25116129
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cannabis and cognitive performance in psychosis: a cross-sectional study in patients with non-affective psychotic illness and their unaffected siblings.
    Meijer JH; Dekker N; Koeter MW; Quee PJ; van Beveren NJ; Meijer CJ;
    Psychol Med; 2012 Apr; 42(4):705-16. PubMed ID: 21899795
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cannabis use and anticipatory pleasure as reported by subjects with early psychosis and community controls.
    Cassidy CM; Lepage M; Harvey PO; Malla A
    Schizophr Res; 2012 May; 137(1-3):39-44. PubMed ID: 22436394
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cannabinoids and psychosis.
    Sewell RA; Ranganathan M; D'Souza DC
    Int Rev Psychiatry; 2009 Apr; 21(2):152-62. PubMed ID: 19367509
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Perceived risk associated with tobacco, alcohol and cannabis use among people with and without psychotic disorders.
    Thornton LK; Baker AL; Johnson MP; Lewin T
    Addict Behav; 2013 Jun; 38(6):2246-51. PubMed ID: 23507458
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cannabis use in children and adolescents with first episode psychosis: influence on psychopathology and short-term outcome (CAFEPS study).
    Baeza I; Graell M; Moreno D; Castro-Fornieles J; Parellada M; González-Pinto A; Payá B; Soutullo C; de la Serna E; Arango C
    Schizophr Res; 2009 Sep; 113(2-3):129-37. PubMed ID: 19427172
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Prospective cohort study of cannabis use, predisposition for psychosis, and psychotic symptoms in young people.
    Henquet C; Krabbendam L; Spauwen J; Kaplan C; Lieb R; Wittchen HU; van Os J
    BMJ; 2005 Jan; 330(7481):11. PubMed ID: 15574485
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.